EMEA-001776-PIP03-17-M01
EMEA-001776-PIP03-17-M01
EMEA-001776-PIP03-17-M01
Opinion/decision on a Paediatric investigation plan (PIP): Rukobia, fostemsavir (tromethamine), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0380/2023
Minutes of the HMPC meeting 22-24 July 2024
Outcome of written procedures finalised during the period from 04 June 2024 to 25 September 2024
Opinion/decision on a Paediatric investigation plan (PIP): Stelara, ustekinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0341/2023
EMEA-003319-PIP02-22
EMEA-003319-PIP03-22
EMEA-003326-PIP01-22
EMEA-003328-PIP01-22
Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1